Olympus Corporation (TYO:7733)
1,768.00
+50.00 (2.91%)
Jul 3, 2026, 3:30 PM JST
Olympus Revenue
In the fiscal year ending March 31, 2026, Olympus had annual revenue of 1.01T JPY with 1.34% growth. Olympus had revenue of 295.28B in the quarter ending March 31, 2026, with 8.51% growth.
Revenue
1.01T
Revenue Growth
+1.34%
P/S Ratio
1.86
Revenue / Employee
35.92M
Employees
28,138
Market Cap
1.88T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.01T | 13.34B | 1.34% |
| Mar 31, 2025 | 997.33B | 61.12B | 6.53% |
| Mar 31, 2024 | 936.21B | 54.29B | 6.16% |
| Mar 31, 2023 | 881.92B | 13.06B | 1.50% |
| Mar 31, 2022 | 868.87B | 138.32B | 18.93% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| FUJIFILM Holdings | 3.36T |
| PHC Holdings | 364.40B |
| Nihon Kohden | 235.10B |
| Fukuda Denshi | 139.70B |
| Japan Lifeline | 59.19B |
| Eiken Chemical | 41.90B |
| Seikagaku | 36.65B |
| Japan Medical Dynamic Marketing, INC. | 23.92B |
Olympus News
- 19 days ago - Olympus downgraded to Neutral from Buy at Goldman Sachs - TheFly
- 7 weeks ago - Olympus Earnings Call Transcript: Q4 2026 - Transcripts
- 7 weeks ago - Olympus Slides: Q4 2026 - Filings
- 7 weeks ago - Olympus Quarterly report: Q4 2026 - Filings
- 5 months ago - Olympus Earnings Call Transcript: Q3 2026 - Transcripts
- 5 months ago - Olympus Quarterly report: Q3 2026 - Filings
- 5 months ago - Olympus Slides: Q3 2026 - Filings
- 8 months ago - Olympus Earnings Call Transcript: Q2 2026 - Transcripts